{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:13:06Z","timestamp":1780452786740,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2020 Taizhou Social Development Science and Technology Plan Project","award":["Project number: 20ywa33"],"award-info":[{"award-number":["Project number: 20ywa33"]}]},{"name":"2023 Taizhou Social Development Science and Technology Plan Project","award":["Project number: 23ywa40"],"award-info":[{"award-number":["Project number: 23ywa40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10735-025-10510-7","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:42:46Z","timestamp":1752140566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long non-coding RNA MINCR silencing contributes to suppressed gemcitabine resistance in bladder cancer by blocking the ZEB1\/PHGDH axis through microRNA-876-5p up-regulation"],"prefix":"10.1007","volume":"56","author":[{"given":"Linfei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"10510_CR1","first-page":"551","volume":"69","author":"S Bai","year":"2022","unstructured":"Bai S, Li Y, Wang Y, Zhou G, Liu C, Xiong W, Chen J (2022) Long non-coding RNA MINCR regulates the growth and metastasis of human osteosarcoma cells via Wnt\/beta-catenin signaling pathway. Acta Biochim Pol 69:551\u2013557","journal-title":"Acta Biochim Pol"},{"key":"10510_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12038-017-9722-5","volume":"42","author":"L Bao","year":"2017","unstructured":"Bao L, Lv L, Feng J, Chen Y, Wang X, Han S, Zhao H (2017) MiR-876-5p suppresses epithelial-mesenchymal transition of lung cancer by directly down-regulating bone morphogenetic protein 4. J Biosci 42:671\u2013681","journal-title":"J Biosci"},{"key":"10510_CR3","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J Cell Biol 220:e202009045","journal-title":"J Cell Biol"},{"key":"10510_CR4","doi-asserted-by":"publisher","first-page":"1087337","DOI":"10.3389\/fcell.2023.1087337","volume":"11","author":"C Chao","year":"2023","unstructured":"Chao C, Tang R, Zhao J, Di D, Qian Y, Wang B (2023) Oncogenic roles and related mechanisms of the long non-coding RNA MINCR in human cancers. Front Cell Dev Biol 11:1087337","journal-title":"Front Cell Dev Biol"},{"key":"10510_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12931-019-1174-z","volume":"20","author":"S Chen","year":"2019","unstructured":"Chen S, Gu T, Lu Z, Qiu L, Xiao G, Zhu X, Li F, Yu H, Li G, Liu H (2019) Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer. Respir Res 20:202","journal-title":"Respir Res"},{"key":"10510_CR6","first-page":"507","volume":"96","author":"KC DeGeorge","year":"2017","unstructured":"DeGeorge KC, Holt HR, Hodges SC (2017) Bladder cancer: diagnosis and treatment. Am Fam Physician 96:507\u2013514","journal-title":"Am Fam Physician"},{"key":"10510_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/medicina57080749","volume":"57","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczudlowski M (2021) Bladder cancer: current challenges and future directions. Medicina (Kaunas) 57:749","journal-title":"Medicina (Kaunas)"},{"key":"10510_CR8","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.2147\/OTT.S216134","volume":"12","author":"N Dong","year":"2019","unstructured":"Dong N, Guo J, Han S, Bao L, Diao Y, Lin Z (2019) Positive feedback loop of lncRNA HOXC-AS2\/miR-876-5p\/ZEB1 to regulate EMT in glioma. Onco Targets Ther 12:7601\u20137609","journal-title":"Onco Targets Ther"},{"key":"10510_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D (2023) Bladder cancer. Nat Rev Dis Primers 9:58","journal-title":"Nat Rev Dis Primers"},{"key":"10510_CR10","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1158\/1078-0432.CCR-21-0422","volume":"27","author":"SL Hasanali","year":"2021","unstructured":"Hasanali SL, Morera DS, Racine RR, Hennig M, Ghosh S, Lopez LE, Hupe MC, Escudero DO, Wang J, Zhu H, Sarcan S, Azih I, Zhou M, Jordan AR, Terris MK, Kuczyk MA, Merseburger AS, Lokeshwar VB (2021) HYAL4-V1\/Chondroitinase (Chase) drives gemcitabine resistance and predicts chemotherapy failure in patients with bladder cancer. Clin Cancer Res 27:4410\u20134421","journal-title":"Clin Cancer Res"},{"key":"10510_CR11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X (2020) miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 16:2628\u20132647","journal-title":"Int J Biol Sci"},{"issue":"9","key":"10510_CR12","first-page":"2196","volume":"18","author":"I Kawahara","year":"2024","unstructured":"Kawahara I, Yoshino H, Fukumoto W, Arima J, Saito S, Li G, Fukuda I, Mitsuke A, Sakaguchi T, Inoguchi S, Matsushita R, Nakagawa M, Tatarano S, Yamada Y, Enokida H (2024) Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models. Mol Oncol 18(9):2196\u20132211","journal-title":"Mol Oncol"},{"key":"10510_CR13","doi-asserted-by":"publisher","first-page":"71881","DOI":"10.18632\/oncotarget.17985","volume":"8","author":"Z Kun-Peng","year":"2017","unstructured":"Kun-Peng Z, Xiao-Long M, Chun-Lin Z (2017) LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget 8:71881\u201371893","journal-title":"Oncotarget"},{"key":"10510_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD (2020) Bladder cancer: a review. JAMA 324:1980\u20131991","journal-title":"JAMA"},{"key":"10510_CR15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s11064-020-03029-8","volume":"45","author":"Z Li","year":"2020","unstructured":"Li Z, Xie X, Fan X, Li X (2020) Long non-coding RNA MINCR regulates miR-876-5p\/GSPT1 axis to aggravate glioma progression. Neurochem Res 45:1690\u20131699","journal-title":"Neurochem Res"},{"key":"10510_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41417-020-00211-6","volume":"28","author":"Y Li","year":"2021","unstructured":"Li Y, Shi B, Dong F, Zhu X, Liu B, Liu Y (2021) LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p\/HS3ST3B1. Cancer Gene Ther 28:212\u2013220","journal-title":"Cancer Gene Ther"},{"key":"10510_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12031-021-01956-x","volume":"72","author":"L Li","year":"2022","unstructured":"Li L, Zhang Q, Yuan L, Yang Y, Wang X, Liu F, Liu Y, Xie M (2022) GNG12 targeted by miR-876-5p contributes to glioma progression through the activation of the PI3K\/AKT signaling pathway. J Mol Neurosci 72:441\u2013450","journal-title":"J Mol Neurosci"},{"key":"10510_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W (2023a) Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat 68:100938","journal-title":"Drug Resist Updat"},{"key":"10510_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154635","volume":"248","author":"Z Li","year":"2023","unstructured":"Li Z, Fu H, Liu J, Song W, Zeng M, Wang J (2023b) LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B. Pathol Res Pract 248:154635","journal-title":"Pathol Res Pract"},{"key":"10510_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Kong Y, An M, Luo Y, Zheng H, Lin Y, Chen J, Yang J, Liu L, Luo B, Huang J, Lin T, Chen C (2023c) ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/beta-catenin pathway. J Exp Clin Cancer Res 42:191","journal-title":"J Exp Clin Cancer Res"},{"key":"10510_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1386207322666190404151020","volume":"22","author":"J Lian","year":"2019","unstructured":"Lian J, Zhang X, Lu Y, Hao S, Zhang Z, Yang Y (2019) Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma. Comb Chem High Throughput Screen 22:201\u2013206","journal-title":"Comb Chem High Throughput Screen"},{"key":"10510_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113490","volume":"153","author":"J Lu","year":"2022","unstructured":"Lu J, Fei F, Wu C, Mei J, Xu J, Lu P (2022) ZEB1: catalyst of immune escape during tumor metastasis. Biomed Pharmacother 153:113490","journal-title":"Biomed Pharmacother"},{"key":"10510_CR23","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.prp.2019.01.041","volume":"215","author":"Q Lyu","year":"2019","unstructured":"Lyu Q, Jin L, Yang X, Zhang F (2019) LncRNA MINCR activates Wnt\/beta-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Pathol Res Pract 215:924\u2013930","journal-title":"Pathol Res Pract"},{"key":"10510_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41420-021-00712-9","volume":"7","author":"X Ma","year":"2021","unstructured":"Ma X, Ying Y, Sun J, Xie H, Li J, He L, Wang W, Chen S, Shen H, Yi J, Luo J, Wang X, Zheng X, Liu B, Xie L (2021) circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p\/ZEB1 axis. Cell Death Discov 7:365","journal-title":"Cell Death Discov"},{"key":"10510_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.critrevonc.2015.05.005","volume":"96","author":"F Massari","year":"2015","unstructured":"Massari F, Santoni M, Ciccarese C, Brunelli M, Conti A, Santini D, Montironi R, Cascinu S, Tortora G (2015) Emerging concepts on drug resistance in bladder cancer: implications for future strategies. Crit Rev Oncol Hematol 96:81\u201390","journal-title":"Crit Rev Oncol Hematol"},{"key":"10510_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP (2021) lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol 75:38\u201348","journal-title":"Semin Cancer Biol"},{"key":"10510_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115242","volume":"165","author":"A Mehmandar-Oskuie","year":"2023","unstructured":"Mehmandar-Oskuie A, Jahankhani K, Rostamlou A, Arabi S, Sadat Razavi Z, Mardi A (2023) Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies. Biomed Pharmacother 165:115242","journal-title":"Biomed Pharmacother"},{"key":"10510_CR28","first-page":"354","volume":"54","author":"Y Mei","year":"2024","unstructured":"Mei Y, Xu J, Li W, Chen S (2024) Gambogic acid improves cisplatin resistance of bladder cancer cells through the epithelial-mesenchymal transition pathway mediated by the miR-205-5p\/ZEB1 axis. Ann Clin Lab Sci 54:354\u2013362","journal-title":"Ann Clin Lab Sci"},{"key":"10510_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/14737140.2016.1143777","volume":"16","author":"K Schlack","year":"2016","unstructured":"Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) The safety and efficacy of gemcitabine for the treatment of bladder cancer. Expert Rev Anticancer Ther 16:255\u2013271","journal-title":"Expert Rev Anticancer Ther"},{"key":"10510_CR30","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00404-022-06423-5","volume":"306","author":"A Shetty","year":"2022","unstructured":"Shetty A, Venkatesh T, Kabbekodu SP, Tsutsumi R, Suresh PS (2022) LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview. Arch Gynecol Obstet 306:1431\u20131447","journal-title":"Arch Gynecol Obstet"},{"key":"10510_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809620","volume":"9","author":"Y Song","year":"2021","unstructured":"Song Y, Du Y, Qin C, Liang H, Yang W, Lin J, Ding M, Han J, Xu T (2021) Gemcitabine-resistant biomarkers in bladder cancer are associated with tumor-immune microenvironment. Front Cell Dev Biol 9:809620","journal-title":"Front Cell Dev Biol"},{"key":"10510_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154568","volume":"248","author":"M Taheri","year":"2023","unstructured":"Taheri M, Askari A, Hussen BM, Eghbali A, Ghafouri-Fard S (2023) A review on the role of MYC-induced long non-coding RNA in human disorders. Pathol Res Pract 248:154568","journal-title":"Pathol Res Pract"},{"key":"10510_CR33","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1158\/0008-5472.CAN-12-3165","volume":"73","author":"YC Teng","year":"2013","unstructured":"Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY, Lin FM, Huang HD, Chen YT, Jeng YM, Hsu CH, Yan Q, Tsai MD, Juan LJ (2013) Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res 73:4711\u20134721","journal-title":"Cancer Res"},{"key":"10510_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2016.06.019","volume":"380","author":"SH Wang","year":"2016","unstructured":"Wang SH, Yang Y, Wu XC, Zhang MD, Weng MZ, Zhou D, Wang JD, Quan ZW (2016) Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Cancer Lett 380:122\u2013133","journal-title":"Cancer Lett"},{"key":"10510_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3892\/ijo.2017.4099","volume":"51","author":"Z Wang","year":"2017","unstructured":"Wang Z, Chen Y, Lin Y, Wang X, Cui X, Zhang Z, Xian G, Qin C (2017) Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Int J Oncol 51:1239\u20131248","journal-title":"Int J Oncol"},{"key":"10510_CR36","first-page":"3837","volume":"18","author":"G Wang","year":"2019","unstructured":"Wang G, Dong Y, Liu H, Ji N, Cao J, Liu A, Tang X, Ren Y (2019) Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1. Oncol Lett 18:3837\u20133844","journal-title":"Oncol Lett"},{"key":"10510_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcmgh.2023.06.006","volume":"16","author":"H Wang","year":"2023","unstructured":"Wang H, Lin F, Xu Z, Yu S, Li G, Liao S, Zhao W, Zhang F, Wang J, Wang S, Ouyang C, Zhang C, Xia H, Wu Y, Jiang B, Li Q (2023) ZEB1 transcriptionally activates PHGDH to facilitate carcinogenesis and progression of HCC. Cell Mol Gastroenterol Hepatol 16:541\u2013556","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10510_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24791","volume":"37","author":"H Wei","year":"2023","unstructured":"Wei H, Yi T, Li Q, Guo Y, Shen C, Jin P (2023) Application of lncRNA-miRNA-mRNA ceRNA network analysis in the treatment of androgenic alopecia. J Clin Lab Anal 37:e24791","journal-title":"J Clin Lab Anal"},{"key":"10510_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41388-020-01634-z","volume":"40","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Ju L, Yuan L, Chen L, Wang G, Xu H, Peng T, Luo Y, Xiao Y, Wang X (2021) KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer. Oncogene 40:1595\u20131608","journal-title":"Oncogene"},{"key":"10510_CR40","first-page":"1458","volume":"18","author":"J Xu","year":"2019","unstructured":"Xu J, Zheng J, Wang J, Shao J (2019) miR-876-5p suppresses breast cancer progression through targeting TFAP2A. Exp Ther Med 18:1458\u20131464","journal-title":"Exp Ther Med"},{"key":"10510_CR41","doi-asserted-by":"publisher","first-page":"BSR20190066","DOI":"10.1042\/BSR20190066","volume":"39","author":"Z Xu","year":"2019","unstructured":"Xu Z, Yu Z, Tan Q, Wei C, Tang Q, Wang L, Hong Y (2019) MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF. Biosci Rep 39:BSR20190066","journal-title":"Biosci Rep"},{"key":"10510_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.631152","volume":"8","author":"K Yi","year":"2021","unstructured":"Yi K, Liu J, Rong Y, Wang C, Tang X, Zhang X, Xiong Y, Wang F (2021) Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer. Front Mol Biosci 8:631152","journal-title":"Front Mol Biosci"},{"key":"10510_CR43","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/1878-0261.12697","volume":"14","author":"H Yoshino","year":"2020","unstructured":"Yoshino H, Enokida H, Osako Y, Nohata N, Yonemori M, Sugita S, Kuroshima K, Tsuruda M, Tatarano S, Nakagawa M (2020) Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine\/cisplatin and the contribution of promoter DNA hypomethylation. Mol Oncol 14:2190\u20132202","journal-title":"Mol Oncol"},{"key":"10510_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110292","volume":"129","author":"Y Yu","year":"2020","unstructured":"Yu Y, Chang Z, Han C, Zhuang L, Zhou C, Qi X, Peng Z (2020) Long non-coding RNA MINCR aggravates colon cancer via regulating miR-708-5p-mediated Wnt\/beta-catenin pathway. Biomed Pharmacother 129:110292","journal-title":"Biomed Pharmacother"},{"key":"10510_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154216","volume":"241","author":"W Yu","year":"2023","unstructured":"Yu W, Ning K, Bai Q, Xiao J (2023) Circ_0001686 knockdown suppresses tumorigenesis and enhances radiosensitivity in esophagus cancer through regulating miR-876-5p\/SPIN1 axis. Pathol Res Pract 241:154216","journal-title":"Pathol Res Pract"},{"key":"10510_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3892\/ol.2020.11680","volume":"20","author":"H Zhao","year":"2020","unstructured":"Zhao H, Zheng Y, You J, Xiong J, Ying S, Xie L, Song X, Yao Y, Jin Z, Zhang C (2020) Tumor suppressor role of miR-876-5p in gastric cancer. Oncol Lett 20:1281\u20131287","journal-title":"Oncol Lett"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10510-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:25:03Z","timestamp":1757219103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10510-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10510"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10510-7","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and ratified by the Ethics Committee of Taizhou Municipal Hospital and obeying the Declaration of Helsinki (Approval number: 2020-KTSJ001), with written informed consent attained from all patients. All animal experiments followed the International Convention on Laboratory Animal Ethics and complied with relevant national regulations. The animal experiments have been carried out in accordance with the ARRIVE guidelines.(Approval number: tzy-202049).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"220"}}